>
If you're a criminal you'll be deported
When Bill Gates isn't investing in dangerous ineffective vaccines, blocking out the sun,...
US dollar exodus to unleash $3.2 trillion 'avalanche' of selling, currency analyst says
Bitcoin ETF Inflows Top Gold ETF Inflows Year-To-Date
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
Dark Matter: An 86-lb, 800-hp EV motor by Koenigsegg
Spacetop puts a massive multi-window workspace in front of your eyes
Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."